The DOI matches its Crossref record; 311 of the 314 references it cites were found in a registry or an index.
Neuroprotective Natural Products for Alzheimer’s Disease
Open accessAbstract
Alzheimer’s disease (AD) is the number one neurovegetative disease, but its treatment options are relatively few and ineffective. In efforts to discover new strategies for AD therapy, natural products have aroused interest in the research community and in the pharmaceutical industry for their neuroprotective activity, targeting different pathological mechanisms associated with AD. A wide variety of natural products from different origins have been evaluated preclinically and clinically for their neuroprotective mechanisms in preventing and attenuating the multifactorial pathologies of AD. This review mainly focuses on the possible neuroprotective mechanisms from natural products that may be beneficial in AD treatment and the natural product mixtures or extracts from different sources that have demonstrated neuroprotective activity in preclinical and/or clinical studies. It is believed that natural product mixtures or extracts containing multiple bioactive compounds that can work additively or synergistically to exhibit multiple neuroprotective mechanisms might be an effective approach in AD drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“such evidence allows us to project a scenario where AD could have possible preventive treatments and/or have a slowing palliative effect in patients who already suffer from it [73,74,75].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [73]
In the citing paper
“Mixtures of drugs or plant extracts might have advantages over single drugs as they can impact different targets simultaneously, which could be a novel and more effective treatment option for AD (Chen et al., 2021).”
From Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease (2022) · cites this paper as Chen et al., 2021
In the citing paper
“Consequently, although the use of some herbs, such as those of C. longa and B. monnieri, have demonstrated slight clinical improvements, many natural products such as polyphenols remain of interest in the treatment of neurodegenerative disorders [203].”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [203]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Chemistry and Biological Activities of Flavonoids: An Overview
Kumar, S., & Pandey, A. K. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/162750 · Cited by 5,178
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Oxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979
Ekor, M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00177 · Cited by 3,919
2013 Alzheimer's disease facts and figures
Thies, W. H., & Bleiler, L. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,372
Flagged first, then by citations
3 of the 314 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Campos, M.R.S. (2019). Chapter 2—Phenolic Compounds: Structure, Classification, and Antioxidant Power. Bioactive Compounds, Woodhead Publishing.
Cited by
Sorted by citations
Items 201–236 of 236
Tamarindus indica fruit pulp in neurodegeneration: a multimodal pharmacological study
Usman, L. A., Ajani, E. O., Akinmoladun, A. C., Ibrahim, R., & Abdulameed, H. T. (2025) · In Silico Pharmacology · doi:10.1007/s40203-025-00481-8
Alzheimer’s Disease Management Through the Gut-Brain Axis
Negi, P., Singh, N., & Sethi, P. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2736-6_17
Emerging Trends in Therapeutic Potential of Curcumin in Alzheimer’s Disease
Bashir, S., Khan, A. S., Gilani, A.-U.-H., & Ahmed, T. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2736-6_6
Lo, T. Y., Chan, A. S. L., Cheung, S. T., Yung, L. Y., Leung, M. M. H., & Wong, Y. H. (2024) · Figshare · doi:10.6084/m9.figshare.26610666
Yadav, V., Murmu, A., Matore, B. W., Das, S., Satpathy, S., Mandal, V., Roy, P. P., Singh, J., & Patra, A. (2025) · South African Journal of Botany · doi:10.1016/j.sajb.2025.12.007
Natural Product Assembly in Nanoformulation: Importance in Neurodegenerative Diseases
Verma, K., Singh, R., Jain, S., & Sharma, S. (2026) · Springer eBooks · doi:10.1007/978-981-95-5088-3_6
Natural Products Chemistry: Advances in Synthetic, Analytical and Bioactivity Studies, Volume II
Ribaudo, G. (2026) · Molecules · doi:10.3390/molecules31020374
Alqhtani, A. N., Eid, A. A., Alharbi, M., Nouh, W. K. B., Alharbi, S. S., Alghamdi, W. M. A., Albalawi, M. M., Hassan, H. M., & Al-Gayyar, M. M. H. (2026) · Physiology International · doi:10.1556/2060.2025.00715
Viewing Marine Natural Products’ Role in Neuronal Hyperarousal
Griffith, C., Liu, K., Pathak, S., Nadar, R. M., Dhanasekaran, M., Vijayarani, K. R., & Narayanan, K. (2026) · Nutritional neurosciences · doi:10.1007/978-981-95-5791-2_7
The therapeutic potential of cytisine and its derivatives in disorders of the central nervous system
Cheng, M., Zhu, D., Chen, S., Jia, J., Xu, J., & Zeng, X. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117853
Sreekumari, G. R., Ng, S.-T., Chen, R. P. ‐., Koshy, K. C., & Baby, S. (2026) · Natural Product Research · doi:10.1080/14786419.2026.2636157
Bioactive compounds from blue–green microalgae
Rahman, M. R., & Hellgardt, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-26502-0.00016-1
Mohamed, H. A., Moustafa, S. F., Abdel-Baki, P. M., Salama, A. A. A., Aboulthana, W. M., & Sokkar, N. M. (2026) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-026-00957-0
Song, G., Zhou, Q., Abbas, M., Baba, N., Ibrahim, Y., & Ugwah-Oguejiofor, C. J. (2026) · Natural Product Communications · doi:10.1177/1934578x261441317
Shinde, P. B., Sathiyanarayanan, A., & Lohidasan, S. (2026) · Journal of Molecular Modeling · doi:10.1007/s00894-026-06711-w · Cited by 1
Ugwah-Oguejiofor, C. J., Okechukwu, P. N., Mathias, S. N., Ofokansi, M. N., & Janakiraman, A. K. (2026) · Studies in natural products chemistry · doi:10.1016/b978-0-443-49144-3.00007-1
Green Coffee Bean Extract Mitigates Alzheimer’s Disease in Male Rats
Abu-Almakarem, A. S., Alzahrani, O. R., Abu‐Khudir, R., Alassar, S. R., El-Said, K. S., Alkhodair, S. A., Banjabi, A. A., Al-Bazi, M. M., Mobasher, M. A., & Soliman, M. M. (2026) · Journal of Food Biochemistry · doi:10.1155/jfbc/5511502
Asava and Arishta for CNS Disorders
Verma, S., & Gupta, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814861126010005
Wasim, M., Zia, S. R., & Ahmad, S. (2026) · Neurochemical Journal · doi:10.1134/s181971242670025x
Phytochemistry of Neuroprotective Compounds
Gunasekaran, B., Hanafi, S., Devi, K., & Ulaganathan, V. (2026) · doi:10.1002/9781394360260.ch2
Choi, J. M., Cho, M. S., Jeong, B. G., Kim, J. H., & Kim, H. Y. (2026) · Korean Journal of Agricultural Science · doi:10.7744/kjoas.530209
Complementary and integrative medicine and women’s health
Edwards, E., Belfer, I., Kelly, B., Sekai, C., & Jean‐Francois, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00005-6
Anyanwu, G. E., CHUKWU, V. O., Nto, N. J., Ojiakor, V. O., & Anyanwu, C. N. (2026) · Behavioral and Brain Functions · doi:10.1186/s12993-026-00348-8 · Cited by 1
Yadav, S., Mahajan, S., Koka, S. S., & N, D. G. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815523126010012
Herbal Drugs and their Active Phytoconstituents used for the Treatment of Alzheimer’s and Dementia
Jain, S. K., Trivedi, R., Goyal, S., Sivchandan, A., MUDGAL, K., Modi, P., & Gandhi, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815523126010007
Natural Products as Effective Treatment Approach for Alzheimer's Disease: In silico Justification
Khamkat, P., Chatterjee, B. K., Barık, V., Sahu, S., & Mukherjee, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815646126010015
Ambamba, B. D. A., Jonathan, M. M. N., Marc, A. F. Y., Sandrine, N. M., Reine, N. M. I., Emmanuel, N., Laurent, N. A., Blonde, N. E. M. L., Alexandra, E. E. F., Ella, F. A., et al. (2026) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2026.08.007
Polysaccharides targeting organelle network dysfunction in Alzheimer's disease: A review
Yu, X., Gao, P., Yao, Q., Yuan, F., & 经维新 (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154255
Trigueiro, R. L., Oliveira, L. G. D. H., & Pantoja, P. D. S. (2026) · Advances in Geriatric Medicine and Research · doi:10.20900/agmr20260025
Hossain, M. S., Amin, M. A., Akter, A., Dutta, A., Sakib, M. S. A., Das, L. C., Islam, M. N., & Rahman, M. M. (2026) · Heliyon · doi:10.1016/j.heliyon.2026.e45453
Taşdemir, İ., Nilofar, N., Zengin, G., Li, M., Ak, G., Motta, C. L., Selvi, S., Acquaticci, L., Angeloni, S., Caprioli, G., et al. (2026) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2026.109421
Kandy, A. T., Selvaraj, D., & Jupudi, S. (2026) · Chemical Papers · doi:10.1007/s11696-026-05625-4
Eraj, A., Khatoon, H., Sımjee, S. U., Aziz, A., & Aziz, S. (2026) · International Journal of Pharmacology · doi:10.31083/ijp54494
Adedayo, B. C., Oyeleye, S. I., Oyelami, O. S., Aro, O. P., Ojo, O. R., & Oboh, G. (2026) · Neurodegenerative Disease Management · doi:10.1080/17582024.2026.2744198
Kamonnat, C., Thongdechsri, S., Kraokaew, P., Niamnont, N., Sobhon, P., & Meemon, K. (2026) · Oxidative Medicine and Cellular Longevity · doi:10.1155/omcl/1471919
Metadata
- Authors
- Chen, X., Drew, J., Berney, W., & Lei, W.
- Affiliations
- Campbell University (US)
- Presbyterian College (US)
- Corresponding author
- Chen, Xin
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-05-25
- Volume
- 10
- Issue
- 6
- Pages
- 1309
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC8225186
- OpenAlex
- W3165481569
- Cited by
- 236
- References
- 314
- Citations by year
- 2026: 41 · 2025: 53 · 2024: 54 · 2023: 54 · 2022: 30 · 2021: 4
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, neuroprotection, natural products, natural product mixtures, plant extracts, neuroprotection mechanism
- MeSH terms
- Alzheimer Disease, Animals, Biological Products, Humans, Neuroprotective Agents, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
